STOCK TITAN

Jade Biosciences, Inc. (JBIO) Net Income by Year

JBIO

Jade Biosciences, Inc. reported a net loss of $127.4M in fiscal year 2025. This represents a decrease of 83.0% from the prior fiscal year. The table below carries 6 fiscal years, from 2020 to 2025, and the quarters Jade Biosciences, Inc. has filed alongside them.

FY2025 annual
Net Income -$127.4M
YoY -83.0%
Source SEC Filings (10-K/10-Q) Latest period Q2 FY2026, ended Jun 30, 2026 Reported Currency USD

Annual figures, oldest first. Point at a bar to read its period.

JBIO Net Income by Fiscal Year

Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

MetricFY2510-KFY2410-KFY2310-KFY2210-KFY2110-KFY2010-K
Net Income-$127.4M-83.0%-$69.6M+7.8%-$75.5M-46.6%-$51.5M-124.3%-$23.0M-138.9%-$9.6M

JBIO Net Income by Quarter

Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.

MetricQ2'2610-QQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-QQ2'2410-QQ1'2410-QQ4'2310-KQ3'2310-Q
Net Income-$55.8M-73.5%-$40.4M-5.8%N/A-$25.2M-54.7%-$32.1M-29.7%-$38.2M-64.6%N/A-$16.3M+16.8%-$24.8M-30.2%-$23.2M-40.4%N/A-$19.6M-44.0%

What net income means

Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line.

More Jade Biosciences, Inc. financials

Frequently Asked Questions

What was Jade Biosciences, Inc.'s net income in fiscal year 2025?

Jade Biosciences, Inc. reported a net loss of $127.4M in fiscal year 2025.

How fast is Jade Biosciences, Inc.'s net income growing?

Jade Biosciences, Inc. (JBIO) net income fell by 83.0% year over year, from -$69.6M to -$127.4M in fiscal year 2025.

How has Jade Biosciences, Inc.'s net income changed over the years?

Across the 6 fiscal years this page covers, Jade Biosciences, Inc. (JBIO) net income went from -$9.6M in fiscal year 2020 to -$127.4M in fiscal year 2025.

Jade Biosciences, Inc. (JBIO) reported -$55.8M in net income in Q2 2026. This represents a decrease of 73.5% from the same quarter a year earlier.

Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line. This page lists what Jade Biosciences, Inc. (JBIO) reported on that line in every period on record.